Pancreatic Cancer Research

ResearcherTokai UniversityActive in the last 2 years

Yuhki Yokoyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8542-8588; OpenAlex author ID A5003041684. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 3 papers

Papers 6

  1. The miR-29b Byproduct MIRTX Shows Superior Anti-tumor Activity, Compared to miR-29b-3p, in Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.17974↗
  2. Therapeutic Potential of miR-4711-5p in Pancreatic Cancer: Antitumor Activity and Mechanistic Insights. Co-author DOI 10.3390/cancers18071104↗
  3. miR-136-5p Preferentially Suppresses Cancer Stem-like Cells in Pancreatic Cancer. First author DOI 10.3390/ijms27083686↗
  4. Lymphocyte Antigen 6 Family Member D (LY6D) Affects Stem Cell Phenotype and Progression of Pancreatic Adenocarcinoma. Co-author DOI 10.21873/anticanres.17300↗
  5. KRT13 is upregulated in pancreatic cancer stem-like cells and associated with radioresistance. First author DOI 10.1093/jrr/rrac091↗
  6. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells. Co-author DOI 10.1093/jrr/rrx033↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hirofumi Yamamoto · 4 shared papers, 2017–2026 · strength 0.69
  2. Masaki Mori · 2 shared papers, 2026 · strength 0.49
  3. Hiroyuki Yamamoto · 2 shared papers, 2026 · strength 0.49
  4. Masahiko Koizumi · 2 shared papers, 2017–2023 · strength 0.25
  5. Masaki Mori · 1 shared paper, 2026 · strength 0.25
  6. Shumpei Okimura · 1 shared paper, 2024 · strength 0.18
  7. Masaki Mori · 1 shared paper, 2024 · strength 0.18
  8. Yuichiro Doki · 1 shared paper, 2024 · strength 0.18
  9. Hidetoshi Eguchi · 1 shared paper, 2024 · strength 0.18
  10. Hidenori Takahashi · 1 shared paper, 2024 · strength 0.18
  11. Wataru Takenaka · 1 shared paper, 2023 · strength 0.18
  12. Kento Tsubouchi · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.